Evaluation Of The Effectiveness Of MIST Ultrasound Therapy For The Healing Of Chronic Wounds

Celleration, Inc.
announced the publication of the results of an important clinical study
Evaluation of the Effectiveness of MIST Ultrasound Therapy for the Healing
of Chronic Wounds. The study was conducted in a tertiary-referral
hospital-based wound clinic. Overall, 69% of the wounds in the study were
healed using an intent- to-treat model. When low-frequency, non-contact
ultrasound (MIST Therapy(R)) was used as a stand-alone device; median time
to healing was 7 weeks. Historic controls were healed with a median time to
healing of 10 weeks; however, a statistically significant number of these
patients required wound-related hospitalization and surgical procedures to
achieve closure compared with the wounds in the present study. These new
findings were published by William J. Ennis, DO, Medical Director of the
Wound Treatment Program, St. James Olympia Fields Hospital, Olympia Fields,
IL the lead investigator in the study in the October 2006 issue of the peer
reviewed journal Advances in Skin & Wound Care.



"We are very excited about the results of this study," commented Kevin
Nickels, CEO. "This is the second clinical study published adding to the
growing body of evidence for MIST Therapy. Celleration, Inc. is committed
to the ongoing development and execution of high quality research to
continually broaden the clinical use of MIST Technology(TM); and to provide
our customers and the health care professionals well designed scientific
studies on which to make evidence based treatment decisions."



Celleration's proprietary non-contact MIST Technology can be used on a
variety of wounds including, acute, traumatic, chronic and dehisced wounds
to promote wound healing. MIST Therapy is a bioactive therapy that promotes
healing through cell stimulation while removing bacteria. It is an advanced
modality for modern wound care, a painless ultrasound device. The use of
MIST Therapy is an attractive technology for health care professionals
since its use affects multiple aspects of a chronic wound to promote
healing. The treatment takes only minutes; it is easy to use, compact and
portable, and comfortable for patients with painful wounds.



About the Company:



Celleration, Inc. a privately held medical device company was founded
in 1999, to develop and commercialize its therapeutic ultrasound platform.
The patented MIST Technology utilizes low intensity ultrasonic sound waves
to produce an energized mist of sterile saline in a non-contact fashion.
Critical to the Company's strategy is ongoing clinical and scientific
research to provide evidence supporting the efficacy of this new
technology.


Celleration, Inc

celleration